Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetaka Eguchi

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Advanced Drug Delivery Reviews|January 10, 2009
Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapyMasahiko Nishiyama, Hidetaka Eguchi
Ageing Research Reviews|November 20, 2002
Can teatime increase one's lifetime?Kei Nakachi, Hidetaka Eguchi, Kazue Imai
Asian Pacific Journal of Cancer Prevention : APJCP|August 17, 2005
Minimal sizes of cases with a susceptible genotype and minimal odds ratios among susceptible individuals in case-control studiesNobuyuki Hamajima, Hironori Mutoh, Hidetaka Eguchi, et al.
Oncogene|August 7, 2003
Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7Yoko Omoto, Hidetaka Eguchi, Yuri Yamamoto-Yamaguchi, et al.
Mutation Research|April 15, 2008
Sixty years of follow-up of Hiroshima and Nagasaki survivors: current progress in molecular epidemiology studiesKei Nakachi, Tomonori Hayashi, Kiyohiro Hamatani, et al.
Breast Cancer (Tokyo, Japan)|March 26, 2011
Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer: novel marker genes and prediction model using the expression levelsHiroshi Sano, Satoru Wada, Hidetaka Eguchi, et al.
Oncology Reports|September 2, 2014
A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10)(p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiationKiyohiro Hamatani, Hidetaka Eguchi, Kazuaki Koyama, et al.
Molecular and Clinical Oncology|January 6, 2022
COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy studyDaike Tong, Masashi Tanaka, Hidetaka Eguchi, et al.
Journal of Medical Microbiology|September 11, 2010
Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer developmentShinobu Imagawa, Masanori Ito, Masaharu Yoshihara, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 10, 2023
Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy studyHiroo Fujitani, Hidetaka Eguchi, Yuta Kochi, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Advanced Drug Delivery Reviews|January 10, 2009
Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapyMasahiko Nishiyama, Hidetaka Eguchi
Ageing Research Reviews|November 20, 2002
Can teatime increase one's lifetime?Kei Nakachi, Hidetaka Eguchi, Kazue Imai
Asian Pacific Journal of Cancer Prevention : APJCP|August 17, 2005
Minimal sizes of cases with a susceptible genotype and minimal odds ratios among susceptible individuals in case-control studiesNobuyuki Hamajima, Hironori Mutoh, Hidetaka Eguchi, et al.
Oncogene|August 7, 2003
Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7Yoko Omoto, Hidetaka Eguchi, Yuri Yamamoto-Yamaguchi, et al.
Mutation Research|April 15, 2008
Sixty years of follow-up of Hiroshima and Nagasaki survivors: current progress in molecular epidemiology studiesKei Nakachi, Tomonori Hayashi, Kiyohiro Hamatani, et al.
Breast Cancer (Tokyo, Japan)|March 26, 2011
Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer: novel marker genes and prediction model using the expression levelsHiroshi Sano, Satoru Wada, Hidetaka Eguchi, et al.
Oncology Reports|September 2, 2014
A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10)(p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiationKiyohiro Hamatani, Hidetaka Eguchi, Kazuaki Koyama, et al.
Molecular and Clinical Oncology|January 6, 2022
COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy studyDaike Tong, Masashi Tanaka, Hidetaka Eguchi, et al.
Journal of Medical Microbiology|September 11, 2010
Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer developmentShinobu Imagawa, Masanori Ito, Masaharu Yoshihara, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 10, 2023
Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy studyHiroo Fujitani, Hidetaka Eguchi, Yuta Kochi, et al.
Pageof 11